Premium
Population Imaging as Valuable Tool for Personalized Medicine
Author(s) -
Völzke H,
Schmidt C O,
Hegenscheid K,
Kühn JP,
Bamberg F,
Lieb W,
Kroemer H K,
Hosten N,
Puls R
Publication year - 2012
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2012.100
Subject(s) - personalized medicine , subclinical infection , clinical pharmacology , precision medicine , medicine , population , medical imaging , genomic medicine , medical physics , bioinformatics , computational biology , pathology , pharmacology , biology , radiology , environmental health
Personalized medicine is commonly regarded as an extension of genomic medicine. However, a personalized treatment should be based solely on the presence or absence of genetic factors. Complex imaging methods supplement the diagnostic picture of an individual patient. Comprehensive imaging in population‐based settings provides information on reference intervals, the predictive value of subclinical findings, and the complex interrelationships among risk factors, subclinical imaging phenotypes, and diseases. Clinical Pharmacology & Therapeutics (2012); 92 4, 422–424. doi: 10.1038/clpt.2012.100